Addiction treatment: promoting a medical approach to substance use

成瘾治疗:提倡以医学方法治疗物质滥用

阅读:1

Abstract

Building on decades of Academy activities related to substance use, this report emphasizes three guiding principles: 1. Drug treatment should be accessible to all drug users seeking care, including those who are incarcerated. Because turning users away when programs are operating at or above capacity represents lost opportunities for care, programs should be prepared to commence treatment at the time users request it. 2. Addiction is a complex, chronic, relapsing illness for which various inpatient, residential, and outpatient treatments are used, depending on the substances involved, the intensity and duration of the addiction, the characteristics and tolerances of the patient, and the circumstances involved. Optimal addiction treatment requires generalists in medical care who are knowledgeable and capable in the areas of diagnosis and management; specialist consultation and care; specific programs dedicated to the acute and chronic care of drug users; and the multidisciplinary participation of appropriately qualified counselors, social workers, and other professionals. 3. Steps need to be taken to reduce the health-related harms associated with injection drug use, including the transmission of human immunodeficiency virus (HIV), hepatitis B and C, and other blood-borne pathogens. Harm reduction incorporates many modalities, such as HIV prevention education, including condom use and safer sex counseling and education; referrals for drug treatment and other health care and social services; interim methadone maintenance; and syringe and needle availability and exchange programs. Each of these interventions represents important medical and public health strategies that may decrease some of the secondary medical consequences of injection drug use.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。